ADMA Biologics, Inc. (ADMA)
USD 17.7
(-4.99%)
USD 17.7
(-4.99%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 258.21 Million | 154.07 Million | 80.94 Million | 42.21 Million | 29.34 Million | 16.98 Million |
| Cost of Revenue | 169.99 Million | 118.81 Million | 79.76 Million | 61.29 Million | 39.5 Million | 42.19 Million |
| Gross Profit | 88.21 Million | 35.26 Million | 1.17 Million | -19.07 Million | -10.15 Million | -25.2 Million |
| Operating Expenses | 66.58 Million | 74.63 Million | 59.54 Million | 45.84 Million | 31.26 Million | 35.07 Million |
| Selling, General and Administrative Expenses | 59.02 Million | 52.45 Million | 42.89 Million | 35.05 Million | 25.91 Million | 22.5 Million |
| Research and Development Expenses | 3.3 Million | 3.61 Million | 3.64 Million | 5.9 Million | 2.34 Million | 3.92 Million |
| Other Expenses | 4.99 Million | 18.55 Million | 13 Million | 4.88 Million | 3.01 Million | -127.12 Thousand |
| Cost and Expenses | 236.58 Million | 193.44 Million | 139.31 Million | 107.13 Million | 70.77 Million | 77.27 Million |
| Operating Income | 21.63 Million | -39.36 Million | -58.37 Million | -64.91 Million | -41.42 Million | -60.28 Million |
| Interest Expense | 25.02 Million | 19.27 Million | 13.05 Million | 11.98 Million | 8.99 Million | 5.52 Million |
| Income Tax Expense | - | 19.27 Million | 12.8 Million | 11.85 Million | 8.76 Million | 5.45 Million |
| Earnings before Tax | -28.23 Million | -65.9 Million | -71.64 Million | -75.74 Million | -48.27 Million | -65.74 Million |
| Net Income | -28.23 Million | -85.18 Million | -84.45 Million | -87.6 Million | -57.04 Million | -65.74 Million |
| Earnings Per Share Basic | -0.13 | -0.43 | -0.61 | -1.02 | -1.05 | -1.45 |
| Earnings Per Share Diluted | -0.13 | -0.43 | -0.61 | -1.02 | -1.05 | -1.45 |
| Weighted Average Shares Outstanding | 223.97 Million | 197.87 Million | 139.57 Million | 86.14 Million | 54.34 Million | 45.18 Million |
| Weighted Average Shares Outstanding (Diluted) | 223.97 Million | 197.87 Million | 139.57 Million | 86.14 Million | 54.34 Million | 45.18 Million |
| Gross Margin | 0.34 | 0.23 | 0.01 | -0.45 | -0.35 | -1.48 |
| EBIT Margin | 0.02 | -0.25 | -0.72 | -1.52 | -1.36 | -3.34 |
| Profit Margin | -0.11 | -0.55 | -1.04 | -2.07 | -1.94 | -3.87 |
| EBITDA | 5.12 Million | -39.72 Million | -53.33 Million | -59.82 Million | -36.02 Million | -56.77 Million |
| Earnings Before Tax Margin | 0.08 | -0.26 | -0.72 | -1.54 | -1.41 | -3.55 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 107.19 Million | 81.87 Million | 258.21 Million | 73.9 Million | 67.27 Million | 60.12 Million |
| Cost of Revenue | 49.88 Million | 42.96 Million | 169.99 Million | 43 Million | 42.62 Million | 43.43 Million |
| Gross Profit | 57.31 Million | 38.91 Million | 88.21 Million | 30.89 Million | 24.65 Million | 16.69 Million |
| Operating Expenses | 18.11 Million | 17.09 Million | 66.58 Million | 16.66 Million | 15.96 Million | 17.16 Million |
| Selling, General and Administrative Expenses | 17.55 Million | 16.64 Million | - | 16.22 Million | 14.72 Million | 14.24 Million |
| Research and Development Expenses | 560 Thousand | 450 Thousand | - | 445.48 Thousand | 595.9 Thousand | 1.4 Million |
| Other Expenses | -16 Thousand | -35 Thousand | -287 Thousand | -101.36 Thousand | -145.82 Thousand | -12.82 Thousand |
| Cost and Expenses | 67.99 Million | 60.05 Million | 236.58 Million | 59.67 Million | 58.58 Million | 60.59 Million |
| Operating Income | 39.2 Million | 21.82 Million | 21.63 Million | 14.23 Million | 8.68 Million | -473.07 Thousand |
| Interest Expense | 3.78 Million | 3.76 Million | 25.02 Million | 6.21 Million | 6.39 Million | 6.29 Million |
| Income Tax Expense | 3.78 Million | 595 Thousand | 8.16 Million | -1.00 | 6.25 Million | 6.28 Million |
| Earnings before Tax | 35.85 Million | 18.4 Million | -28.23 Million | -17.64 Million | 2.56 Million | -6.37 Million |
| Net Income | 32.06 Million | 17.8 Million | -28.23 Million | -17.64 Million | 2.56 Million | -6.37 Million |
| Earnings Per Share Basic | 0.14 | 0.08 | - | -0.08 | 0.01 | -0.03 |
| Earnings Per Share Diluted | 0.13 | 0.08 | - | -0.08 | 0.01 | -0.03 |
| Weighted Average Shares Outstanding | 232.41 Million | 228.87 Million | 223.97 Million | 225.96 Million | 225.27 Million | 222.68 Million |
| Weighted Average Shares Outstanding (Diluted) | 242.16 Million | 236.41 Million | 223.97 Million | 225.96 Million | 233.76 Million | 222.68 Million |
| Gross Margin | 0.53 | 0.48 | 0.34 | 0.42 | 0.37 | 0.28 |
| EBIT Margin | 0.38 | 0.29 | - | 0.22 | 0.16 | 0.03 |
| Profit Margin | 0.30 | 0.22 | -0.11 | -0.24 | 0.04 | -0.11 |
| EBITDA | 41.24 Million | 23.93 Million | - | 16.34 Million | 11.05 Million | 2.02 Million |
| Earnings Before Tax Margin | 0.37 | 0.27 | 0.08 | 0.19 | 0.13 | -0.01 |
GTBO
CYIENTDLM
LVH
9663
NVRO
NRL